Monday, December 23, 2024

Smartaly and Ambiq Develop Energy Efficient AI-Enabled Medical-Grade ECG Monitor

Related stories

Doc.com Expands AI developments to Revolutionize Healthcare Access

Doc.com, a pioneering healthcare technology company, proudly announces the development...

Amesite Announces AI-Powered NurseMagic™ Growth in Marketing Reach to Key Markets

Amesite Inc., creator of the AI-powered NurseMagic™ app, announces...

Quantiphi Joins AWS Generative AI Partner Innovation Alliance

Quantiphi, an AI-first digital engineering company, has been named...
spot_imgspot_img

Ambiq, a technology leader in ultra-low power semiconductors to enable local AI on devices, partners with Smartaly, a designer of electronics to develop an energy-efficient and intelligent handheld electrocardiogram (ECG) monitor, tested in hospitals for widespread use.

Smartaly’s handheld ECG relies on the Apollo3 SoC with built-in AI to monitor and detect the heart’s electrical activities 24/7 for up to one week on battery. With more than 99% accuracy, the ECG can notify the users of any abnormality or disturbance in real time for immediate response. The Smartaly ECG is lightweight and can last one year on standby mode. It connects via Bluetooth to other smart devices, giving users actionable insight into their health data.

“We are very proud to have taken on this global challenge of providing the medical sector with a portable, battery-powered electrocardiogram (ECG) monitor,” says Arnaud Duclap, CEO of Smartaly. “We chose Ambiq’s Apollo3 SoC for its perfect match of processing power, high memory, and extremely low power consumption to run the embedded neural network engine. We hope to further participate in other medical projects to contribute to the well-being of people.”

Also Read: Microsoft announces collaboration with NVIDIA to accelerate healthcare and life sciences innovation with advanced cloud, AI and accelerated computing capabilities

“Our partnership with Smartaly is a strategic move to accelerate their development of digital health devices,” says Mike Kenyon, VP of Sales and Business Development at Ambiq, “The medical field is an extremely important industry that requires consistent and data-driven monitoring. Helping medical devices overcome their power constraints to provide insightful health analysis that patients can depend on is exactly what we envision with the Smartaly ECG Monitor.”

The Apollo3 is Ambiq’s third generation of systems on chip (SoC), providing industry-leading ultra-low power and performance for applications ranging from digital health devices to tracking units for pets, wildlife, and animal husbandry. Built upon Ambiq‘s Subthreshold Power Optimization Technology (SPOT) platform, the Apollo3 reduces power consumption to 6µA/MHz in active mode and 1 μA in deep sleep mode.

SOURCE: GlobeNewswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img